Evidence map›Paper›PMID 30664464›Full record

ArticleJMIR cancer2019

Self-Care Behaviors of Ovarian Cancer Patients Before Their Diagnosis: Proof-of-Concept Study.

James M Flanagan, Hanna Skrobanski, Xin Shi, Yasemin Hirst

Registry-linked trialAbstract read
In one paragraph

Article in JMIR cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03994653 (Cancer Loyalty Card Study), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03994653 completednot on this map

Cancer Loyalty Card Study: a Retrospective Observational Case-Control Study

TypeobservationalSponsorImperial College LondonRan2019 to 2022Enrolled963ConditionsOvarian NeoplasmsArmsRisk Factor Questionnaire, Clinical Questionnaire
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

James M Flanagan *Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.ORCID http://orcid.org/0000-0003-4955-1383
Hanna SkrobanskiInstitute of Epidemiology and Public Health, Research Department of Behavioural Science and Health, University College London, London, United Kingdom.ORCID http://orcid.org/0000-0003-0868-8914
Xin ShiBusiness School, Manchester Metropolitan University, Manchester, United Kingdom.ORCID http://orcid.org/0000-0002-4930-7295
Yasemin HirstInstitute of Epidemiology and Public Health, Research Department of Behavioural Science and Health, University College London, London, United Kingdom.ORCID http://orcid.org/0000-0002-0167-9428

Funding

Cancer Research UK 22876Cancer Research UK 26726
6 · The paper itself

Abstract

backgroundLonger patient intervals can lead to more late-stage cancer diagnoses and higher mortality rates. Individuals may delay presenting to primary care with red flag symptoms and instead turn to the internet to seek information, purchase over-the-counter medication, and change their diet or exercise habits. With advancements in machine learning, there is the potential to explore this complex relationship between a patient's symptom appraisal and their first consultation at primary care through linkage of existing datasets (eg, health, commercial, and online).

objectiveHere, we aimed to explore feasibility and acceptability of symptom appraisal using commercial- and health-data linkages for cancer symptom surveillance.

methodsA proof-of-concept study was developed to assess the general public's acceptability of commercial- and health-data linkages for cancer symptom surveillance using a qualitative focus group study. We also investigated self-care behaviors of ovarian cancer patients using high-street retailer data, pre- and postdiagnosis.

resultsUsing a high-street retailer's data, 1118 purchases-from April 2013 to July 2017-by 11 ovarian cancer patients and one healthy individual were analyzed. There was a unique presence of purchases for pain and indigestion medication prior to cancer diagnosis, which could signal disease in a larger sample. Qualitative findings suggest that the public are willing to consent to commercial- and health-data linkages as long as their data are safeguarded and users of this data are transparent about their purposes.

conclusionsCancer symptom surveillance using commercial data is feasible and was found to be acceptable. To test efficacy of cancer surveillance using commercial data, larger studies are needed with links to individual electronic health records.

Indexed as

acceptabilitycancercancer surveillancedata linkageearly diagnosisfocus groupproof of concept

Identifiers

PMID30664464
PMCPMC6354198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.